• Health & Medicine

Kidney cancer immunotherapy combo approved for NHS use in England

A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England. A combination of immunotherapy drugs will be made available to NHS patients with advanced and aggressive kidney cancer on the NHS in England.

5 April 2019

• Health & Medicine

Advanced breast cancer drug combo approved for NHS in England

A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England. A new drug combo has been made available to some patients with advanced breast cancer on the NHS in England.

3 April 2019

• Health & Medicine

Lung cancer immunotherapy approved for NHS patients in England

An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer. An immunotherapy drug will be made available on the NHS in England for certain people with lung cancer.

28 March 2019

• Health & Medicine

Cancer Research UK, LifeArc and Ono Pharma form cancer immunotherapy alliance

New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today. New immunotherapy drug targets for cancer will be progressed through a multimillion-pound drug discovery alliance announced today.

27 March 2019

• Health & Medicine

Special offers fuel obese shoppers

Shoppers whose supermarket trolleys are stacked with food and drink offered on special promotions have more than a 50% increased chance of being obese. Shoppers whose supermarket trolleys are stacked with food and drink offered on special promotions have more than a 50% increased chance of being obese.

27 March 2019

• Health & Medicine

Targeted lymphoma drug gets green light for NHS in England

People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England. People with a certain type of lymphoma will now have access to a targeted cancer drug, called brentuximab vedotin, on the NHS in England.

22 March 2019

• Health & Medicine
• Policy & Insight

Cancer doctor shortage ‘will impact patients’, says Royal College

A shortage of cancer doctors in the NHS is likely to impact patients, according to a new report. A shortage of cancer doctors in the NHS is likely to impact patients, according to a new report.

20 March 2019

• Health & Medicine

Breast cancer death rates continue to fall in UK

Breast cancer death rates will fall in the UK and across nearly all EU countries in 2019, a new study predicts. Breast cancer death rates will fall in the UK and across nearly all EU countries in 2019, a new study predicts.

19 March 2019

• Health & Medicine
• Policy & Insight

Government proposes banning junk food ads before 9pm

Junk food adverts on TV and online could be banned before 9pm as part of Government plans to help tackle childhood obesity. Junk food adverts on TV and online could be banned before 9pm as part of Government plans to help tackle childhood obesity.

18 March 2019

• Health & Medicine
• Policy & Insight

Stop Smoking Services stubbed out across England

Government funding cuts have led to declining Stop Smoking Services across England, a new report has revealed. Government funding cuts have led to declining Stop Smoking Services across England, a new report has revealed.

15 March 2019

• Health & Medicine
• Policy & Insight

Action needed to stop takeaway temptation harming kids' diets

Fast food takeaways should be prevented from setting up business near to schools in Wales, according to a major new poll by Cancer Research UK. Fast food takeaways should be prevented from setting up business near to schools in Wales, according to a major new poll by Cancer Research UK.

15 March 2019

• Health & Medicine

Molecular patterns could better predict breast cancer recurrence

New research suggests the genetic and molecular make-up of individual breast tumours holds clues to how a woman’s disease could progress. New research suggests the genetic and molecular make-up of individual breast tumours holds clues to how a woman’s disease could progress.

13 March 2019